Weight Management Certificate
ACPE Numbers: Various - see below Release Date: January 15, 2025 Expiration Date: January 15, 2028 Activity Type: Application-based CE Credit Hours: 20.5 contact hours |
Overview
Weight management is a struggle for many patients, and we are experiencing an obesity epidemic as a result. Both physiologic and psychologic aspects influence weight management, and this professional certificate looks at holistic patient care to address and manage this multi-layered issue. Upon completion of all the modules, participants should be proficient in the current understanding of weight management pathophysiology, using patient-centered interviewing techniques related to managing what is a sensitive topic for many patients, medications that induce obesity, coordinating complex weight management care, and methods of weight management, including lifestyle modifications, pharmacotherapy, alternative therapies, considerations for special populations, and surgical interventions.
Weight Management Certificate Requirement
Once a learner has completed the educational curriculum, they will have the opportunity to complete an online comprehensive exam. Once the learner completes the exam (minimum 80% passing rate; unlimited attempts permitted), they will earn the professional certificate.
Accreditation
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
Target Audience
This continuing pharmacy education activity is intended for pharmacists seeking to expand their knowledge and skills in weight management.
Course Modules
Learning Activity |
ACPE Number |
Contact Hours |
Introduction to Weight Management and Its Pathophysiology |
0204-0000-25-700-H01-P |
1.25 |
Patient-Centered Language and Motivational Interviewing |
0204-0000-25-701-H04-P |
2.0 |
Clinical Methodology and Weight-Loss Goals |
0204-0000-25-702-H01-P |
1.75 |
Lifestyle Modifications |
0204-0000-25-703-H01-P |
3.0 |
Medication-Induced Obesity |
0204-0000-25-704-H01-P |
1.5 |
Anti-Obesity Pharmacotherapy: Part 1 |
0204-0000-25-705-H01-P |
2.25 |
Anti-Obesity Pharmacotherapy: Part 2 |
0204-0000-25-706-H01-P |
2.25 |
Comorbid Conditions |
0204-0000-25-707-H01-P |
1.25 |
Surgical Interventions |
0204-0000-25-708-H01-P |
1.5 |
Special Populations |
0204-0000-25-709-H01-P |
1.75 |
Interdisciplinary Team Collaborations |
0204-0000-25-710-H04-P | 2.0 |
→ Final Assessment: (80% passing score required) |
Learning Objectives
Introduction to Weight Management and Its Pathophysiology
ACPE: 0204-0000-25-700-H01-P
Activity Type: Application
1.25 contact hours
Learning Objectives:
- Summarize weight management trends for obesity prevalence and predicted prevalence for 2030.
- Apply weight and obesity-related definitions.
- Assess the economic burden of obesity and weight issues.
- Summarize the pathophysiology of obesity.
Patient-Centered Language and Motivational Interviewing
ACPE: 0204-0000-25-701-H04-P
Activity Type: Application
2 contact hours
Learning Objectives:
- Identify examples of person-centered and strengths-based language for use in person-centered communication.
- Use patient-centered language.
- Employ the purpose, fundamental principles, and skills of motivational interviewing in strengths-based weight management conversations.
- Apply the principles and skills of motivational interviewing in person-centered communication.
Clinical Methodology and Weight-Loss Goals
ACPE: 0204-0000-25-702-H01-P
Activity Type: Application
1.75 contact hours
Learning Objectives:
- Recommend an appropriate weight loss strategy.
- Use a person-centered, clinical approach (e.g., the 5As of Obesity Management) for weight management.
- Differentiate the staging of body weight according to national guidelines.
- Evaluate assessment tools and methods for weight management.
- Summarize the challenges associated with the use of assessment tools for weight management.
- Apply evidence-based guidelines on weight-loss goals to individuals with weight issues or obesity.
- Develop individualized weight-loss goals for different types of patient scenarios.
Lifestyle Modifications
ACPE:0204-0000-25-703-H01-P
Activity Type: Application
3 contact hours
Learning Objectives:
- Recommend patient-specific nutrition and lifestyle modifications for weight management based on national-level guidelines.
- Determine appropriate energy needs for patients based on gender, age, physical activity level, and special circumstances.
- Compare dietary patterns for weight management.
- Define the exercise, physical activity, and sedentary behavior recommended guidelines.
- Identify the principles of exercise behavior and the FITT principle.
- Assess different types of exercise and components of an exercise routine.
- Apply exercise concepts and strategies to weight management exercise prescriptions including contraindications for exercise.
- Differentiate between evidence-based behavioral weight loss programs.
- Summarize evidence-based behavioral strategies for weight loss, including the use of mobile apps.
- Identify psychological and medical comorbidities that interfere with weight loss.
Medication-Induced Obesity
ACPE: 0204-0000-25-704-H01-P
Activity Type: Application
1.5 contact hours
Learning Objectives:
- Assess the effect of specific medications for treating other medical conditions on weight management.
- Compare treatment regimens for certain disease states to minimize medication induced weight gain.
- Given a patient case, develop a plan to promote weight loss.
Anti-Obesity Pharmacotherapy: Part 1
ACPE: 0204-0000-25-705-H01-P
Activity Type: Application
2.25 contact hours
Learning Objectives:
- Describe guidance from the Food and Drug Administration for weight management.
- Differentiate treatment recommendations for pharmacological options in weight management.
- Differentiate treatment recommendations for weight management.
- Assess drug therapy efficacy and safety through evidence-based medicine.
- Recommend drug therapy for specific patient case scenarios.
Anti-Obesity Pharmacotherapy: Part 2
ACPE: 0204-0000-25-706-H01-P
Activity Type: Application
2.25 contact hours
Learning Objectives:
- Categorize differences of FDA and non-FDA approved medications for facilitating weight loss.
- Analyze evidence related to investigational and off-label therapy use in weight loss and management.
- Given a patient case, assess investigational and off-label drug therapy use for weight management.
- Analyze evidence related to alternative therapy use in weight loss and management.
- Counsel on safety and efficacy of alternative therapies used in weight loss and weight management.
Comorbid Conditions
ACPE: 0204-0000-25-707-H01-P
Activity Type: Application
1.25 contact hours
Learning Objectives:
- Assess comorbid conditions and challenges that arise from being overweight or obese.
- Identify specific risk factors for developing unique comorbid conditions.
- Compare strategies to lessen the risk of developing comorbid conditions.
- Design a plan for a patient presenting with obesity and comorbid conditions.
Surgical Interventions
ACPE: 0204-0000-25-708-H01-P
Activity Type: Application
1.5 contact hours
Learning Objectives:
- Apply guideline recommendations for obesity-related surgical interventions.
- Plan pre-surgical care for patients.
- Differentiate between types of surgical interventions for weight management.
- Apply knowledge of weight management surgical interventions to the management of medications in post-operative patients.
- Manage nutritional deficiencies in patients after weight management surgery.
Special Populations
ACPE: 0204-0000-25-709-H01-P
Activity Type: Application
1.75 contact hours
Learning Objectives:
- Apply weight loss treatment guidelines to pregnant or pediatric patients.
- Evaluate lifestyle modifications, pharmacotherapy interventions, and surgical interventions for pregnant or pediatric patients.
- Given a patient case, design an evidence-based weight loss treatment regimen for a pregnant patient.
- Assess complications of obesity within special populations.
- Apply lifestyle modifications, pharmacotherapy, interventions, and surgical interventions for special populations.
- Design a treatment plan for weight loss for a person within a special population.
Interdisciplinary Team Collaborations
ACPE: 0204-0000-25-710-H04-P
Activity Type: Application
2 contact hours
Learning Objectives:
- Analyze how the core elements of the Chronic Care Model support optimization of chronic diseases.
- Assess how pharmacists may contribute to a Chronic Care Model.
- Develop a plan for onboarding c-suite and health-system leadership for a weight management program.
- Evaluate the role of a pharmacist for weight management in a variety of clinical settings.
- Apply strategies for measuring success and continuous quality improvements in a weight management program.
Faculty
Nicole Albanese, PharmD, BCACP CDCES
Clinical Associate Professor
University at Buffalo
Residency Program Director
Buffalo Medical Group
Buffalo, New York
Nicholas Carris, PharmD, BCPS
Associate Professor
University of South Florida
Tampa, Florida
Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM
Clinical Professor
Director of Pharmacy Education
University of South Carolina College of Pharmacy
Greenville, South Carolina
Cassandra Hobbs, PharmD, MBA, BCACP, LDE
Associate Professor
Sullivan University College of Pharmacy and Health Sciences
Louisville, Kentucky
Jan Kavookjian, PhD, MBA, FAPhA, FADCES
Associate Professor, Health Outcomes Research & Policy
Auburn University Harrison School of Pharmacy
Auburn, Alabama
Emily McCoy, PharmD, BCACP
Associate Clinical Professor
Auburn University Harrison School of Pharmacy
Adjunct Assistant Professor
Department of Internal Medicine, University of South Alabama College of Medicine
Mobile, Alabama
Anne Misher, PharmD, MBA, BCACP, BC-ADM, CDCES, CPP
Pharmacy Supervisor
Novant Health
Gastonia, North Carolina
Katherine O'Neal, PharmD, MBA, AE-C, BCACP, BC-ADM, CDCES, CLS, FADCES
Associate Professor
University of Oklahoma College of Pharmacy
Oklahoma City, Oklahoma
Sherry Pagoto, PhD
Professor
University of Connecticut
Storrs, Connecticut
April Miller Quidley, PharmD, BCCCP, BCPS, FCCM, FCCP
Manager, Academic Pharmacy Services
ECU Health Medical Center
Greenville, North Carolina
Sara Reece, PharmD, BCACP, BC-ADM, CDCES, FADCES
Associate Professor and Vice Chair, Pharmacy Practice, and Director of IPE SOP
Philadelphia College of Osteopathic Medicine
Georgia Campus School of Pharmacy
Suwanee, Georgia
Ambulatory Care Pharmacist and Core Faculty
Northeast Georgia Medical Center Family Medicine GME Program
Gainesville, Georgia
Daniel Riche, PharmD, FCCP, CLS, ASH-CHC
Professor
University of Mississippi – School of Pharmacy
University, Mississippi
Pamela Stamm, PharmD, BCPS, BCACP, CDCES, FASHP, FCCP
Associate Professor, Pharmacy Practice
Auburn University – Harrison College of Pharmacy
Auburn, Alabama
Danielle Wadsworth, PhD, FACSM
Endowed Professor, Director of the Exercise Adherence and Obesity Prevention Laboratory
School of Kinesiology, Auburn University
Auburn, Alabama
Heather Whitley, PharmD, BCPS, CDCES, FCCP
Clinical Professor
Auburn University Harrison College of Pharmacy
Auburn, Alabama
Clinical Pharmacy Specialist
Baptist Family Medicine, Baptist Health System
Montgomery, Alabama
Relevant Financial Relationship Disclosure
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
The following persons in control of this activity’s content have relevant financial relationships:
- Jennifer Clements: Novo Nordisk (Speaker's Bureau); Eli Lilly (Speaker's Bureau)
All other persons in control of content do not have any relevant financial relationships with an ineligible company.
Methods and CE Requirements
Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity.
Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.
Important Note – ACPE 60 Day Deadline:
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, check your NABP profile account to validate that your credits were transferred successfully before the ACPE 60-day deadline. After the 60-day deadline, ASHP will no longer be able to award credit for this activity.
The ASHP PROFESSIONAL CERTIFICATES℠ educational product line contains learning activities that are ACPE-accredited knowledge and application-based continuing education. This is not an ACPE Certificate Program. Upon successful completion of the activities, the learner will be able to download an ASHP Professional Certificate.